Determinants of prolactin in postmenopausal Chinese women in Singapore
- PMID: 29124543
- PMCID: PMC5962355
- DOI: 10.1007/s10552-017-0978-8
Determinants of prolactin in postmenopausal Chinese women in Singapore
Abstract
Purpose: Mechanistic and observational data together support a role for prolactin in breast cancer development. Determinants of prolactin in Asian populations have not been meaningfully explored, despite the lower risk of breast cancer in Asian populations.
Methods: Determinants of plasma prolactin were evaluated in 442 postmenopausal women enrolled in the Singapore Chinese Health Study, a population-based prospective cohort study. At baseline all cohort members completed an in-person interview that elicited information on diet, menstrual and reproductive history, and lifestyle factors. One year after cohort initiation we began collecting blood samples. Quantified were plasma concentrations of prolactin, estrone, estradiol, testosterone, androstenedione, and sex hormone-binding globulin (SHBG). Analysis of covariance method was used for statistical analyses with age at blood draw, time since last meal, and time at blood draw as covariates.
Results: Mean prolactin levels were 25.1% lower with older age at menarche (p value = 0.001), and 27.6% higher with greater years between menarche and menopause (p value = 0.009). Prolactin levels were also positively associated with increased sleep duration (p value = 0.005). The independent determinants of prolactin were years from menarche to menopause, hours of sleep, and the plasma hormones estrone and SHBG (all p values < 0.01).
Conclusion: The role of prolactin in breast cancer development may involve reproductive and lifestyle factors, such as a longer duration of menstrual cycling and sleep patterns.
Keywords: Breast cancer; Chinese; Hormones; Menstrual factors; Prolactin; Sleep.
Conflict of interest statement
Similar articles
-
Lifetime cumulative number of menstrual cycles and serum sex hormone levels in postmenopausal women.Breast Cancer Res Treat. 2008 Mar;108(1):101-12. doi: 10.1007/s10549-007-9574-z. Epub 2007 May 22. Breast Cancer Res Treat. 2008. PMID: 18274909 Free PMC article.
-
Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden).Cancer Causes Control. 2003 Sep;14(7):599-607. doi: 10.1023/a:1025671317220. Cancer Causes Control. 2003. PMID: 14575357
-
Menstrual cycle characteristics and steroid hormone, prolactin, and growth factor levels in premenopausal women.Cancer Causes Control. 2017 Dec;28(12):1441-1452. doi: 10.1007/s10552-017-0971-2. Epub 2017 Oct 31. Cancer Causes Control. 2017. PMID: 29086892 Free PMC article.
-
Endogenous and exogenous endocrine factors.Hematol Oncol Clin North Am. 1989 Dec;3(4):577-98. Hematol Oncol Clin North Am. 1989. PMID: 2691490 Review.
-
Systematic Review and Meta-Analysis of Lifestyle and Reproductive Factors Associated with Risk of Breast Cancer in Asian Women.Cancer Epidemiol Biomarkers Prev. 2024 Oct 2;33(10):1273-1285. doi: 10.1158/1055-9965.EPI-24-0005. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 39018331 Free PMC article.
Cited by
-
Sleep Disturbances Across a Woman's Lifespan: What Is the Role of Reproductive Hormones?J Endocr Soc. 2023 Mar 15;7(5):bvad036. doi: 10.1210/jendso/bvad036. eCollection 2023 Mar 6. J Endocr Soc. 2023. PMID: 37091307 Free PMC article. Review.
References
-
- Perks CM, Keith AJ, Goodhew KL, Savage PB, Winters ZE, Holly JM. Prolactin acts as a potent survival factor for human breast cancer cell lines. Br J Cancer. 2004;91(2):305–311. https://doi.org/10.1038/sj.bjc.6601947. - DOI - PMC - PubMed
-
- Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C, Nicolas A, Trivin C, Postel-Vinay MC, Kuttenn F, Kelly PA. Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metab. 1998;83(2):667–674. https://doi.org/10.1210/jcem.83.2.4564. - DOI - PubMed
-
- Rose-Hellekant TA, Arendt LM, Schroeder MD, Gilchrist K, Sandgren EP, Schuler LA. Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice. Oncogene. 2003;22(30):4664–4674. https://doi.org/10.1038/sj.onc.1206619. - DOI - PMC - PubMed
-
- Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest. 1997;100(11):2744–2751. https://doi.org/10.1172/JCI119820. - DOI - PMC - PubMed
-
- Arendt LM, Rugowski DE, Grafwallner-Huseth TA, Garcia-Barchino MJ, Rui H, Schuler LA. Prolactininduced mouse mammary carcinomas model estrogen resistant luminal breast cancer. Breast Cancer Res. 2011;13(1):R11. https://doi.org/10.1186/bcr2819. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous